Literature DB >> 25236466

Genetic analysis of the UPB1 gene in two new Chinese families with β-ureidopropionase deficiency and the carrier frequency of the mutation c.977G>A in Northern China.

Jianbo Shu1, Xiqian Lv, Shuzhen Jiang, Yuqin Zhang, Chunhua Zhang, Yingtao Meng, Aiming Situ, Haiquan Xu, Li Song.   

Abstract

PURPOSE: The purpose of the study was to investigate mutations of the UPB1 gene in two Chinese families with β-ureidopropionase deficiency and the heterozygous carrier frequency in Chinese.
METHODS: Genomic DNA was extracted from peripheral blood leukocytes from all available family members and 500 unrelated healthy controls. Then, all exons and flanking intron regions of the UPB1 gene were amplified by PCR and analyzed by direct sequencing in two patient-families. Finally, the carrier frequency of the c.977G>A (p.R326Q) mutation was identified by PCR restriction fragment length polymorphism in 500 healthy controls.
RESULTS: The two patients had the same homozygous missense mutation in exon 9 (c.977G>A; p.R326Q), and the carrier frequency of this mutation was 2.8 % in the Northern Chinese population, which suggests that about 1:5,102 Chinese are expected to suffer from UPB1 deficiency.
CONCLUSIONS: The c.977G>A (p.R326Q) is the most common mutation of the UPB1 gene in Chinese. The predicted incidence indicates that β-ureidopropionase deficiency is significantly underdiagnosed in the Chinese population. It should be necessary to add β-ureidopropionase deficiency to high-risk screening for the symptomatic patients group.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25236466     DOI: 10.1007/s00381-014-2541-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  17 in total

1.  3-Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis.

Authors:  S Kölker; J G Okun; F Hörster; B Assmann; B Ahlemeyer; D Kohlmüller; S Exner-Camps; E Mayatepek; J Krieglstein; G F Hoffmann
Journal:  J Neurosci Res       Date:  2001-11-15       Impact factor: 4.164

2.  Clinical findings and a therapeutic trial in the first patient with beta-ureidopropionase deficiency.

Authors:  B Assmann; G Göhlich; M Baethmann; R A Wevers; A H Van Gennip; A B P Van Kuilenburg; C Dietrich; L Wagner; J J Rotteveel; J Schaper; E Mayatepek; G F Hoffmann; T Voit
Journal:  Neuropediatrics       Date:  2006-02       Impact factor: 1.947

3.  cDNA cloning, genomic structure and chromosomal localization of the human BUP-1 gene encoding beta-ureidopropionase.

Authors:  P Vreken; A B van Kuilenburg; N Hamajima; R Meinsma; H van Lenthe; G Göhlich-Ratmann; B E Assmann; R A Wevers; A H van Gennip
Journal:  Biochim Biophys Acta       Date:  1999-10-28

4.  Contribution of the β-ureidopropionase (UPB1) gene alterations to the development of fluoropyrimidine-related toxicity.

Authors:  Julie Fidlerova; Petra Kleiblova; Stanislav Kormunda; Jan Novotny; Zdenek Kleibl
Journal:  Pharmacol Rep       Date:  2012       Impact factor: 3.024

Review 5.  Effects of β-aminoisobutyric acid on leptin production and lipid homeostasis: mechanisms and possible relevance for the prevention of obesity.

Authors:  Karima Begriche; Julie Massart; Bernard Fromenty
Journal:  Fundam Clin Pharmacol       Date:  2009-09-03       Impact factor: 2.748

6.  A novel domain of the inhibitory glycine receptor determining antagonist efficacies: further evidence for partial agonism resulting from self-inhibition.

Authors:  V Schmieden; J Kuhse; H Betz
Journal:  Mol Pharmacol       Date:  1999-09       Impact factor: 4.436

7.  Beta-aminoisobutyric acid prevents diet-induced obesity in mice with partial leptin deficiency.

Authors:  Karima Begriche; Julie Massart; Adjé Abbey-Toby; Anissa Igoudjil; Philippe Lettéron; Bernard Fromenty
Journal:  Obesity (Silver Spring)       Date:  2008-09       Impact factor: 5.002

8.  Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism.

Authors:  Holly R Thomas; Hany H Ezzeldin; Vincenzo Guarcello; Lori K Mattison; Brooke L Fridley; Robert B Diasio
Journal:  Pharmacogenet Genomics       Date:  2008-01       Impact factor: 2.089

9.  Screening and diagnosis of beta-ureidopropionase deficiency by gas chromatographic/mass spectrometric analysis of urine.

Authors:  Morimasa Ohse; Masafumi Matsuo; Akihito Ishida; Tomiko Kuhara
Journal:  J Mass Spectrom       Date:  2002-09       Impact factor: 1.982

10.  Clinical, biochemical and molecular analysis of 13 Japanese patients with β-ureidopropionase deficiency demonstrates high prevalence of the c.977G > A (p.R326Q) mutation [corrected].

Authors:  Yoko Nakajima; Judith Meijer; Doreen Dobritzsch; Tetsuya Ito; Rutger Meinsma; Nico G G M Abeling; Jeroen Roelofsen; Lida Zoetekouw; Yoriko Watanabe; Kyoko Tashiro; Tomoko Lee; Yasuhiro Takeshima; Hiroshi Mitsubuchi; Akira Yoneyama; Kazuhide Ohta; Kaoru Eto; Kayoko Saito; Tomiko Kuhara; André B P van Kuilenburg
Journal:  J Inherit Metab Dis       Date:  2014-02-14       Impact factor: 4.982

View more
  3 in total

1.  Case Report: A Case of β-Ureidopropionase Deficiency Complicated With MELAS Syndrome Caused by UPB1 Variant and Mitochondrial Gene Variant.

Authors:  Jianbo Shu; Xiufang Zhi; Jing Chen; Meifang Lei; Jie Zheng; Wenchao Sheng; Chunhua Zhang; Dong Li; Chunquan Cai
Journal:  Front Pediatr       Date:  2022-02-21       Impact factor: 3.418

2.  Exome sequencing for paediatric-onset diseases: impact of the extensive involvement of medical geneticists in the diagnostic odyssey.

Authors:  Christopher Cy Mak; Gordon Kc Leung; Gary Tk Mok; Kit San Yeung; Wanling Yang; Cheuk-Wing Fung; Sophelia Hs Chan; So-Lun Lee; Ni-Chung Lee; Rolph Pfundt; Yu-Lung Lau; Brian Hy Chung
Journal:  NPJ Genom Med       Date:  2018-08-06       Impact factor: 8.617

3.  Clinical and genetic analysis of 7 Chinese patients with β-ureidopropionase deficiency.

Authors:  Yulian Fang; Chunquan Cai; Chao Wang; Bei Sun; Xinjie Zhang; Wenxuan Fan; Wenchao Hu; Yingtao Meng; Shuxiang Lin; Chunhua Zhang; Yuqin Zhang; Jianbo Shu
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.